Vimarsana
Biggest News Aggregation in the World

Research Development Day News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research Development Day. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Development Day Today - Breaking & Trending Today

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day - Vimarsana News

Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day

Live Webcast Scheduled to Begin at 9 am EDT Today ...

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024 - Vimarsana News

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024

Aldeyra Therapeutics, Inc. , a clinical-stage biotechnology company developing innovative therapies for the treatment of immune-mediated and metabolic diseases, today announced that the company will...

Moderna : R&D Day Reflections with CFO Jamey Mock -September 25, 2023 at 05:35 pm EDT - Vimarsana News

Moderna : R&D Day Reflections with CFO Jamey Mock -September 25, 2023 at 05:35 pm EDT

View All News R&D Day Reflections with CFO Jamey Mock September 25, 2023 Earlier this month, we hosted our seventh...

Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day - Vimarsana News

Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day

Submitted a new drug application (NDA) for troriluzole in Spinocerebellar Ataxia Type 3 (SCA3) to U.S. FDA in 2Q2023, marking the team's fourth NDA in...

Molecular Templates, Inc. to Present Interim Data and Host - Vimarsana News

Molecular Templates, Inc. to Present Interim Data and Host

AUSTIN, Texas, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage...